> Product Porfolio
Peginterferon
Description
Pegylation is a process of attaching the strands of the polymer PEG to molecules most typically peptides, proteins, and antibody fragments, that can help to meet the challenges of improving the safety and efficiency of many therapeutics. Pegylation, by increasing the molecular weight of a molecule, can impart several significant pharmacological advantages over the unmodified form, such as: improved drug solubility, reduced dosage frequency without diminished efficacy with potentially reduced toxicity, extended circulating life, increased drug stability and enhanced protection from proteolytic degradation.

Indications
· Chronic Hepatitis C
· Chronic Hepatitis B
· Cancer
· Solid tumor
· Renal cancer
· Genitourinary cancer
· Viral infection